Literature DB >> 32702499

STAT3: A key regulator in liver fibrosis.

Jie Zhao1, Yong-Fen Qi2, Yan-Rong Yu3.   

Abstract

Janus protein tyrosine kinase (JAK) has the ability to activate signal transducer and activator of transcription (STAT). STAT3 is a valued member of the JAK/STAT signaling pathway. In recent years, several studies have documented that STAT3 is closely related to the occurrence and development of liver fibrosis caused by various factors. Activation of STAT3 can play anti- or pro-inflammatory roles in the pathogenesis of liver fibrosis. This article reviewed the recent studies on STAT3 in the development of various liver fibrosis to find a more effective method to relieve and cure liver diseases, such as hepatitis B virus (HBV), non-alcoholic fatty liver disease (NAFLD), schistosomiasis, and chemical liver injury.
Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chemical Liver injury; HBV; Liver fibrosis; NAFLD; STAT3; Schistosomiasis

Year:  2020        PMID: 32702499     DOI: 10.1016/j.aohep.2020.06.010

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  19 in total

1.  Verapamil inhibited the development of ureteral stricture by blocking CaMK II-mediated STAT3 and Smad3/JunD pathways.

Authors:  Zhibiao Qing; Wuxiong Yuan; Jiansong Wang; Wei Song; Jianjun Luo; Xuecheng Wu; Qiang Lu; Yuanwei Li; Mingqiang Zeng
Journal:  Int Urol Nephrol       Date:  2022-08-03       Impact factor: 2.266

2.  Role of Th17 Cytokines in the Liver's Immune Response during Fatal Yellow Fever: Triggering Cell Damage Mechanisms.

Authors:  Marcos Luiz Gaia Carvalho; Luiz Fábio Magno Falcão; Jeferson da Costa Lopes; Caio Cesar Henriques Mendes; Fábio Alves Olímpio; Vanessa do Socorro Cabral Miranda; Lais Carneiro Dos Santos; Daniel Dias Pinheiro de Moraes; Marcos Virgilio Bertonsin Filho; Luccas Delgado da Costa; Raimunda do Socorro da Silva Azevedo; Ana Cecília Ribeiro Cruz; Vanessa Costa Alves Galúcio; Lívia Caricio Martins; Maria Irma Seixas Duarte; Arnaldo Jorge Martins Filho; Jorge Rodrigues de Sousa; Pedro Fernando da Costa Vasconcelos; Juarez Antônio Simões Quaresma
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

3.  AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway.

Authors:  Xuan Wu; Yuhong Luo; Shan Wang; Yueying Li; Meiyu Bao; Yuanjiang Shang; Lei Chen; Weiwei Liu
Journal:  Redox Biol       Date:  2022-05-06       Impact factor: 10.787

Review 4.  The Great Healing Potential Hidden in Plant Preparations of Antioxidant Properties: A Return to Nature?

Authors:  Małgorzata Kiełczykowska; Irena Musik
Journal:  Oxid Med Cell Longev       Date:  2020-10-09       Impact factor: 6.543

5.  ConsensusPathDB 2022: molecular interactions update as a resource for network biology.

Authors:  Atanas Kamburov; Ralf Herwig
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

6.  Characterization of wild-type and STAT3 signaling-suppressed mesenchymal stem cells obtained from hemovac blood concentrates.

Authors:  Dong Hwan Lee; Seon Ae Kim; Eun Jeong Go; Chi Young Yoon; Mi-La Cho; Asode Ananthram Shetty; Seok Jung Kim
Journal:  Ann Transl Med       Date:  2021-08

Review 7.  New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.

Authors:  Maria D Giraldez; David Carneros; Christoph Garbers; Stefan Rose-John; Matilde Bustos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-01       Impact factor: 46.802

Review 8.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

Review 9.  Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Sayali Bhave; Han Kiat Ho
Journal:  Biomedicines       Date:  2021-11-26

10.  Perturbed transcriptional profiles after chronic low dose rate radiation in mice.

Authors:  Hildegunn Dahl; Dag M Eide; Torstein Tengs; Nur Duale; Jorke H Kamstra; Deborah H Oughton; Ann-Karin Olsen
Journal:  PLoS One       Date:  2021-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.